Bednarek-Tupikowska G, Stachowska B, Miazgowski T, et al. Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol Pol 2012; 63(6): 447–455.
Zdrojewski T, Rutkowski M, Bandosz P, et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NAT POL 2011 Survey. Kardiol Pol 2013; 71(4): 381–392.
Milewicz A. Fenotyp otyłości a skład masy ciała i profil metaboliczny. Endokrynol Otyłość 2005; 1(1): 15–19.
Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients 2013; 5(6): 2019–2027.
Bergmann K, Olender K, Odrowąż-Sypniewska G. Rola otyłości i stanu zapalnego w cukrzycy typu 2 – znane fakty, nowe kontrowersje.Diagn Lab 2012; 48(3): 313–322
Brenner DR, Tepylo K, Eny KM, et al. Comparison of body mass index and waist circumference as predictors of cardiometabolic health in a population of young Canadian adults. Diabet Metab Syndr 2010; 2(1): 28.
Czernichow S, Kengne AP, Stamatakis E, et al. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev 2011; 12(9): 680–687
Miazgowski T, Krzyzanowska-Świniarska B, Wolanin-Prost B, et al. Prospective evaluation of visceral fat in patients with type 2 diabetes by densitometry using a new CoreScan application. Diabet Klin 2013; 2(6): 213–219.
Minderico CS, Silva AM, Keller K, et al. Usefulness of different techniques for measuring body composition changes during weight loss in overweight and obese women. Br J Nutr 2008; 99(2): 432–441.
Cyganek K, Katara B, Sieradzki J. Porównanie pomiarów tkanki tłuszczowej u otyłych pacjentów z zastosowaniem metody impedancji bioelektrycznej i densytometrycznej. Diabet Prakt 2007; 8(12): 473–478.
Physical status: the use and interpretation of anthropometry. Report of a W HO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1–452.
Wytyczne ESH/ESC dotyczące postępowania w nadciśnieniu tętniczym w 2013 roku. Nadciś Tętn 2013; 17(2): 69–168.
Stępińska J, Solnica B, Kulpa J, i wsp. Konieczność ujednolicenia wartości docelowych wyników badań lipidowych w medycznych laboratoriach diagnostycznych w Polsce. Diagn Lab 2012; 48(4): 473–474.
Lohman T, Houtkooper L, Going S. Body fat measurements goes High-Tech: not all are created equal. ACSM’S Health Fitn J 1997; 1(1): 30–35.
Phillips CM, Tierney AC , Perez-Martinez P, et al. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 2013; 21(1): E154–E161.
Wróblewska I, Lewicka M, Blaszczuk J. Life style and risk of myocardial infarction. Research in the Opole voivodship. Fam Med Prim Care Rev 2013; 15(2): 202–204.
Lesser IA , Gasevic D, Lear SA. The effect of body fat distribution on ethnic differences in cardiometabolic risk factors of Chinese and Europeans. Applied Physiol Nutr Metabol 2013; 38(7): 701–706.
Sieminska L. Adipose tissue. Pathophysiology, distribution, sex differences and the role in inflammation and cancerogenesis.Endokrynol Pol 2007; 58(4): 330–342.
Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003; 254(6): 555–563.
Lutosławska G, Malara M, Tomaszewski P, et al. Relationship between the percentage of body fat and surrogate indices of fatness in male and female Polish active and sedentary students. J Physiol Anthropol 2014; 33: 10.
Płaczkowska S, Kokot I, Pawlik-Sobecka L, et al. Indices of insulin resistance in Wroclaw university students – preliminary report. Fam Med Prim Care Rev 2013; 15(3): 370–371.
Bucyk B, Tupikowska M, Bednarek-Tupikowska G. Kryteria rozpoznania zespołu metabolicznej otyłości z prawidłowa masą ciała (MONW ). Endokrynol Otyłość 2007; 5(4): 226–232